TAO Synergies (TAOX) Capital Expenditures (2020 - 2025)
TAO Synergies' (TAOX) quarterly Capital Expenditures came in at $10.6 million in Q4 2025, down 19.09% quarter-over-quarter from $13.1 million in Q3 2025.
Analysis
TAO Synergies (TAOX) Capital Expenditures (2020 - 2025) Analysis & Trends
TAO Synergies (TAOX) has reported Capital Expenditures for 4 consecutive years, with $10.6 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Capital Expenditures changed N/A year-over-year to $10.6 million; the trailing twelve-month figure through Dec 2025 stood at $23.6 million (changed N/A YoY), and the FY2025 full-year result was $28.1 million, changed N/A from the prior year.
- Capital Expenditures eased to $10.6 million in Q4 2025 per TAOX's latest filing, from $13.1 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $13.1 million in Q3 2025 and bottomed at $669.0 in Q2 2023.
- Historically, Capital Expenditures has averaged $3.9 million across 3 years, with a median of $2192.5 in 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.88 Bn | 197.89 Bn | 7.24 Bn | 513.00 Mn |
| 2 | Gilead Sciences | 181.55 Bn | 178.37 Bn | 6.22 Bn | 140.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.31 Bn | 124.45 Bn | 2.84 Bn | 112.20 Mn |
| 4 | Regeneron Pharmaceuticals | 82.51 Bn | 74.52 Bn | 3.93 Bn | 240.20 Mn |
| 5 | Argenx Se | 61.54 Bn | 56.36 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.69 Bn | 49.55 Bn | 52.00 Mn | 37.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.07 Bn | 30.76 Bn | 992.69 Mn | 34.68 Mn |
| 8 | Biogen | 31.41 Bn | 30.12 Bn | 1.96 Bn | 40.90 Mn |
| 9 | Roivant Sciences | 30.10 Bn | 30.10 Bn | 1.16 Mn | -1.87 Mn |
| 10 | TAO Synergies | 30.93 Mn | 30.93 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 10.57 Mn |
| Sep 30, 2025 | 13.07 Mn |
| Jun 30, 2023 | 669.00 |
| Mar 31, 2023 | 2,038.00 |
| Dec 31, 2022 | 2,139.00 |
| Sep 30, 2022 | 2,246.00 |
| Jun 30, 2020 | 2,814.00 |
| Mar 31, 2020 | 2,599.00 |